Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee

Journal of Cardiac Failure

Volumn 21, Issue 8, 2015, Pages 674-693

  Colvin, Monica ^a   Sweitzer, Nancy K ^b   Albert, Nancy M ^c   Krishnamani, Rajan ^d   Rich, Michael W ^e   Stough, Wendy Gattis ^f   Walsh, Mary Norine ^g   Westlake Canary, Cheryl A ^h   Allen, Larry A ⁱ   Bonnell, Mark R ^j   Carson, Peter E ^k   Chan, Michael C ^l   Dickinson, Michael G ^m   Dries, Daniel L ⁿ   Ewald, Gregory A ^e   Fang, James C ^o   Hernandez, Adrian F ^p   Hershberger, Ray E ^q   Katz, Stuart D ^r   Moore, Stephanie ^s   Rodgers, Jo E ^t   Rogers, Joseph G ^p   Vest, Amanda R ^u   Whellan, David J ^v   Givertz, Michael M ^w   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Advanced Cardiovascular Institute   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CAMPBELL UNIVERSITY   (United States)

^g St Vincent s Heart Center of Indiana   (United States)

^h AZUSA PACIFIC UNIVERSITY   (United States)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TOLEDO   (United States)

^k GEORGETOWN UNIVERSITY   (United States)

^l UNIVERSITY OF ALBERTA   (Canada)

^m SPECTRUM HEALTH   (United States)

ⁿ TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

^o UNIVERSITY OF UTAH   (United States)

^p DUKE UNIVERSITY MEDICAL CENTER   (United States)

^q OHIO STATE UNIVERSITY   (United States)

^r NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s MASSACHUSETTS GENERAL HOSPITAL   (United States)

^t University of North Carolina   (United States)

^u TUFTS MEDICAL CENTER   (United States)

^v THOMAS JEFFERSON UNIVERSITY   (United States)

^w HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

African American; elderly; Heart failure; women

Indexed keywords

ALDOSTERONE ANTAGONIST; BENAZEPRIL; BISOPROLOL; BUCINDOLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIURETIC AGENT; ENALAPRIL; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; LISINOPRIL; LOSARTAN; METOPROLOL; METOPROLOL SUCCINATE; MINERALOCORTICOID ANTAGONIST; RAMIPRIL; SPIRONOLACTONE; VALSARTAN;

AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; ASSISTED CIRCULATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL TRIAL (TOPIC); COMORBIDITY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HISPANIC; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR ASSIST DEVICE; LIFE EXPECTANCY; MEDICAL SOCIETY; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOUTH ASIAN; TREATMENT RESPONSE; UNITED STATES; ADULT; ETHNIC GROUP; ETHNOLOGY; MIDDLE AGED; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PROCEDURES; WOMEN'S HEALTH;

ADULT; ETHNIC GROUPS; FEMALE; GUIDELINES AS TOPIC; HEART FAILURE; HUMANS; MIDDLE AGED; PRECISION MEDICINE; SOCIETIES, MEDICAL; WOMEN'S HEALTH;

EID: 84938293575     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2015.05.013     Document Type: Article

References (220)

1. A. Heiat, C.P. Gross, and H.M. Krumholz Representation of the elderly, women, and minorities in heart failure clinical trials Arch Intern Med 162 2002 1682 1688
2. E.M. Hsich, and I.L. Pina Heart failure in women: a need for prospective data J Am Coll Cardiol 54 2009 491 498
3. A. Sharma, M. Colvin-Adams, and C.W. Yancy Heart failure in African Americans: disparities can be overcome Cleve Clin J Med 81 2014 301 311
4. C.W. Yancy Heart failure in African Americans Am J Cardiol 96 2005 3i 12i
5. B.K. Nallamothu, R.A. Hayward, and E.R. Bates Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies Circulation 118 2008 1294 1303
6. D. Reynolds, N.M. Albert, A.B. Curtis, M. Gheorghiade, J.T. Heywood, M.L. McBride, and et al. Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF J Natl Med Assoc 104 2012 287 298
7. D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, and et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 2015 e29 e322
8. P.A. Heidenreich, N.M. Albert, L.A. Allen, D.A. Bluemke, J. Butler, G.C. Fonarow, and et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association Circ Heart Fail 6 2013 606 619
9. H. Bahrami, R. Kronmal, D.A. Bluemke, J. Olson, S. Shea, K. Liu, and et al. Differences in the incidence of congestive heart failure by ethnicity: the Multi-Ethnic Study of Atherosclerosis Arch Intern Med 168 2008 2138 2145
10. M.D. Sosin, G.S. Bhatia, R.C. Davis, and G.Y. Lip Heart failure - the importance of ethnicity Eur J Heart Fail 6 2004 831 843
11. L.R. Loehr, W.D. Rosamond, P.P. Chang, A.R. Folsom, and L.E. Chambless Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study) Am J Cardiol 101 2008 1016 1022
12. K. Bibbins-Domingo, M.J. Pletcher, F. Lin, E. Vittinghoff, J.M. Gardin, A. Arynchyn, and et al. Racial differences in incident heart failure among young adults N Engl J Med 360 2009 1179 1190
13. D.L. Dries, D.V. Exner, B.J. Gersh, H.A. Cooper, P.E. Carson, and M.J. Domanski Racial differences in the outcome of left ventricular dysfunction N Engl J Med 340 1999 609 616
14. S.E. Lipshultz, L.A. Sleeper, J.A. Towbin, A.M. Lowe, E.J. Orav, G.F. Cox, and et al. The incidence of pediatric cardiomyopathy in two regions of the United States N Engl J Med 348 2003 1647 1655
15. S.S. Coughlin, J.R. Labenberg, and M.C. Tefft Black-white differences in idiopathic dilated cardiomyopathy: the Washington DC Dilated Cardiomyopathy Study Epidemiology 4 1993 165 172
16. D.K. Gupta, A.M. Shah, D. Castagno, M. Takeuchi, L.R. Loehr, E.R. Fox, and et al. Heart failure with preserved ejection fraction in African Americans: the ARIC (Atherosclerosis Risk In Communities) study JACC Heart Fail 1 2013 156 163
17. C. Cardillo, C.M. Kilcoyne, R.O. Cannon III, and J.A. Panza Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation Hypertension 31 1998 1235 1239
18. A.A. Morris, R.S. Patel, J.N. Binongo, J. Poole, I. Al Mheid, Y. Ahmed, and et al. Racial differences in arterial stiffness and microcirculatory function between black and white Americans J Am Heart Assoc 2 2013 e002154
19. S.R. Mulukutla, L. Venkitachalam, C. Bambs, K.E. Kip, A. Aiyer, O.C. Marroquin, and et al. Black race is associated with digital artery endothelial dysfunction: results from the Heart SCORE study Eur Heart J 31 2010 2808 2815
20. J.M. Flack, D.A. Sica, G. Bakris, A.L. Brown, K.C. Ferdinand, R.H. Grimm Jr., and et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement Hypertension 56 2010 780 800
21. J. Wang, W. Chen, L. Ruan, A. Toprak, S.R. Srinivasan, and G.S. Berenson Differential effect of elevated blood pressure on left ventricular geometry types in black and white young adults in a community (from the Bogalusa Heart Study) Am J Cardiol 107 2011 717 722
22. D.L. Dries, R.G. Victor, J.E. Rame, R.S. Cooper, X. Wu, X. Zhu, and et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension Circulation 112 2005 2403 2410
23. J.E. Rame, M.H. Drazner, W. Post, R. Peshock, J. Lima, R.S. Cooper, and et al. Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload Hypertension 49 2007 857 864
24. W. Wang, X. Liao, K. Fukuda, S. Knappe, F. Wu, D.L. Dries, and et al. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity Circ Res 103 2008 502 508
25. D.M. McNamara, S.W. Tam, M.L. Sabolinski, P. Tobelmann, K. Janosko, A.L. Taylor, and et al. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial J Am Coll Cardiol 48 2006 1277 1282
26. K. Lindpaintner, M. Lee, M.G. Larson, V.S. Rao, M.A. Pfeffer, J.M. Ordovas, and et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass N Engl J Med 334 1996 1023 1028
27. N. Iwai, N. Ohmichi, Y. Nakamura, and M. Kinoshita DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy Circulation 90 1994 2622 2628
28. M.V. Raynolds, M.R. Bristow, E.W. Bush, W.T. Abraham, B.D. Lowes, L.S. Zisman, and et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy Lancet 342 1993 1073 1075
29. H. Schunkert, H.W. Hense, S.R. Holmer, M. Stender, S. Perz, U. Keil, and et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy N Engl J Med 330 1994 1634 1638
30. K. Duru, S. Farrow, J.M. Wang, W. Lockette, and T. Kurtz Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension Am J Hypertens 7 1994 759 762
31. B. Yu, Y. Zheng, D. Alexander, T.A. Manolio, A. Alonso, J.A. Nettleton, and et al. Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study Genet Epidemiol 37 2013 840 845
32. K.M. Small, L.E. Wagoner, A.M. Levin, S.L. Kardia, and S.B. Liggett Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure N Engl J Med 347 2002 1135 1142
33. S.O. Henderson, C.A. Haiman, and W. Mack Multiple polymorphisms in the renin-angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort Am J Med Sci 328 2004 266 273
34. K.H. Asl, M. Nakamura, T. Yamashita, and M.D. Benson Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family Amyloid 8 2001 263 269
35. D. Jacobson, C. Tagoe, A. Schwartzbard, A. Shah, J. Koziol, and J. Buxbaum Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men Am J Cardiol 108 2011 440 444
36. J. Buxbaum, A. Alexander, J. Koziol, C. Tagoe, E. Fox, and D. Kitzman Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) studies Am Heart J 159 2010 864 870
37. D.R. Jacobson, P.D. Gorevic, and J.N. Buxbaum A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology Am J Hum Genet 47 1990 127 136
38. T. Nwankwo, S.S. Yoon, V. Burt, and Q. Gu Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012 NCHS Data Brief 2013 1 8
39. R.P. Vivo, S.R. Krim, C. Cevik, and R.M. Witteles Heart failure in Hispanics J Am Coll Cardiol 53 2009 1167 1175
40. G.W. Moe, and J. Tu Heart failure in the ethnic minorities Curr Opin Cardiol 25 2010 124 130
41. R.M. Cubbon, S.R. Murgatroyd, C. Ferguson, T.S. Bowen, M. Rakobowchuk, V. Baliga, and et al. Human exercise-induced circulating progenitor cell mobilization is nitric oxide-dependent and is blunted in South Asian men Arterioscler Thromb Vasc Biol 30 2010 878 884
42. J.E. Sanderson, S.K. Chan, W.W. Chan, Y.T. Hung, and K.S. Woo The aetiology of heart failure in the Chinese population of Hong Kong - a prospective study of 730 consecutive patients Int J Cardiol 51 1995 29 35
43. D. Choi, E. Nemi, C. Fernando, M. Gupta, and G.W. Moe Differences in the clinical characteristics of ethnic minority groups with heart failure managed in specialized heart failure clinics JACC Heart Fail 2 2014 392 399
44. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.G. Stough, M. Gheorghiade, B.H. Greenberg, and et al. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF) Am J Cardiol 104 2009 107 115
45. D.M. Lloyd-Jones, M.G. Larson, E.P. Leip, A. Beiser, R.B. d'Agostino, W.B. Kannel, and et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 2002 3068 3072
46. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
47. K.L. Thomas, and E.J. Velazquez Therapies to prevent heart failure post-myocardial infarction Curr Heart Fail Rep 2 2005 174 182
48. A. Chieffo, G.L. Buchanan, F. Mauri, J. Mehilli, B. Vaquerizo, A. Moynagh, and et al. ACS and STEMI treatment: gender-related issues Eurointervention 8 Suppl P 2012 P27 P35
49. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, and K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
50. D. Levy, S. Kenchaiah, M.G. Larson, E.J. Benjamin, M.J. Kupka, K.K. Ho, and et al. Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402
51. A.L. Bui, T.B. Horwich, and G.C. Fonarow Epidemiology and risk profile of heart failure Nat Rev Cardiol 8 2011 30 41
52. C.S. Lam, E. Donal, E. Kraigher-Krainer, and R.S. Vasan Epidemiology and clinical course of heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 18 28
53. C.S. Lam, P.E. Carson, I.S. Anand, T.S. Rector, M. Kuskowski, M. Komajda, and et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) trial Circ Heart Fail 5 2012 571 578
54. M. Senni, C.M. Tribouilloy, R.J. Rodeheffer, S.J. Jacobsen, J.M. Evans, K.R. Bailey, and et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 1998 2282 2289
55. M.M. McDermott, J. Feinglass, P.I. Lee, S. Mehta, B. Schmitt, F. Lefevre, and et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure Am Heart J 134 1997 728 736
56. M.M. McDermott, J. Feinglass, J. Sy, and M. Gheorghiade Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy Am J Med 99 1995 629 635
57. F.P. Brouwers, R.A. de Boer, P. van der Harst, A.A. Voors, R.T. Gansevoort, S.J. Bakker, and et al. Incidence and epidemiology of new onset heart failure with preserved vs reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Eur Heart J 34 2013 1424 1431
58. J.E. Ho, A. Lyass, D.S. Lee, R.S. Vasan, W.B. Kannel, M.G. Larson, and et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction Circ Heart Fail 6 2013 279 286
59. J.S. Saczynski, A.S. Go, D.J. Magid, D.H. Smith, D.D. McManus, L. Allen, and et al. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study J Am Geriatr Soc 61 2013 26 33
60. K. Bibbins-Domingo, F. Lin, E. Vittinghoff, E. Barrett-Connor, S.B. Hulley, D. Grady, and et al. Predictors of heart failure among women with coronary disease Circulation 110 2004 1424 1430
61. A.D. Pradhan, P.J. Skerrett, and J.E. Manson Obesity, diabetes, and coronary risk in women J Cardiovasc Risk 9 2002 323 330
62. J.S. Gottdiener, A.M. Arnold, G.P. Aurigemma, J.F. Polak, R.P. Tracy, D.W. Kitzman, and et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 35 2000 1628 1637
63. V. Lazzarini, R.J. Mentz, M. Fiuzat, M. Metra, and C.M. O'Connor Heart failure in elderly patients: distinctive features and unresolved issues Eur J Heart Fail 15 2013 717 723
64. S.F. Mohammed, S.A. Mirzoyev, W.D. Edwards, A. Dogan, D.R. Grogan, S.M. Dunlay, and et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction JACC Heart Fail 2 2014 113 122
65. N.S. Beckett, R. Peters, A.E. Fletcher, J.A. Staessen, L. Liu, D. Dumitrascu, and et al. Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898
66. B. Greenberg, M.A. Quinones, C. Koilpillai, M. Limacher, D. Shindler, C. Benedict, and et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy Circulation 91 1995 2573 2581
67. National Center for Health Statistics Deaths: final data for 2012 Natl Vital Stat Rep 2015 1 85
68. V. Vaccarino, E. Gahbauer, S.V. Kasl, P.A. Charpentier, D. Acampora, and H.M. Krumholz Differences between African Americans and whites in the outcome of heart failure: evidence for a greater functional decline in African Americans Am Heart J 143 2002 1058 1067
69. D.W. Brown, G.A. Haldeman, J.B. Croft, W.H. Giles, and G.A. Mensah Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000 Am Heart J 150 2005 448 454
70. E. Arias United States life tables, 2010 Natl Vital Stat Rep 63 2014 1 63
71. P.P. Chang, L.E. Chambless, E. Shahar, A.G. Bertoni, S.D. Russell, H. Ni, and et al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study) Am J Cardiol 113 2014 504 510
72. R.J. Mentz, V. Bittner, P.J. Schulte, J.L. Fleg, I.L. Pina, S.J. Keteyian, and et al. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure-A Controlled Trial Investigating Outcomes in Exercise Training (HF-ACTION) Am Heart J 166 2013 488 495
73. K.L. Thomas, M.A. East, E.J. Velazquez, R.H. Tuttle, L.K. Shaw, C.M. O'Connor, and et al. Outcomes by race and etiology of patients with left ventricular systolic dysfunction Am J Cardiol 96 2005 956 963
74. P.N. Peterson, E.J. Campagna, M. Maravi, L.A. Allen, S. Bull, J.F. Steiner, and et al. Acculturation and outcomes among patients with heart failure Circ Heart Fail 5 2012 160 166
75. J.E. Rame, S.W. Tam, D. McNamara, M. Worcel, M.L. Sabolinski, A.H. Wu, and et al. Dysfunctional corin I555(P568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy Circ Heart Fail 2 2009 541 548
76. K.F. Adams Jr., C.A. Sueta, M. Gheorghiade, C.M. O'Connor, T.A. Schwartz, G.G. Koch, and et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study Circulation 99 1999 1816 1821
77. T. Simon, M. Mary-Krause, C. Funck-Brentano, and P. Jaillon Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II) Circulation 103 2001 375 380
78. M. Martinez-Selles, R.N. Doughty, K. Poppe, G.A. Whalley, N. Earle, C. Tribouilloy, and et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis Eur J Heart Fail 14 2012 473 479
79. E. O'Meara, T. Clayton, M.B. McEntegart, J.J. McMurray, I.L. Pina, C.B. Granger, and et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Circulation 115 2007 3111 3120
80. I. Vaartjes, A.W. Hoes, J.B. Reitsma, B.A. de, D.E. Grobbee, A. Mosterd, and et al. Age- and gender-specific risk of death after first hospitalization for heart failure BMC Public Health 10 2010 637
81. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, and et al. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
82. G.Y. Stein, T. Ben-Gal, A. Kremer, T. Bental, D. Alon, R. Korenfeld, and et al. Gender-related differences in hospitalized heart failure patients Eur J Heart Fail 15 2013 734 741
83. S. Parashar, R. Katz, N.L. Smith, A.M. Arnold, V. Vaccarino, N.K. Wenger, and et al. Race, gender, and mortality in adults ≥65 years of age with incident heart failure (from the Cardiovascular Health Study) Am J Cardiol 103 2009 1120 1127
84. F. Rodriguez, Y. Wang, C.E. Johnson, and J.M. Foody National patterns of heart failure hospitalizations and mortality by sex and age J Card Fail 19 2013 542 549
85. S. Meyer, P. van der Meer, B.M. Massie, C.M. O'Connor, M. Metra, P. Ponikowski, and et al. Sex-specific acute heart failure phenotypes and outcomes from PROTECT Eur J Heart Fail 15 2013 1374 1381
86. E.M. Hsich, M.V. Grau-Sepulveda, A.F. Hernandez, E.D. Peterson, L.H. Schwamm, D.L. Bhatt, and et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction Am Heart J 163 2012 430 437
87. J. Chen, K. Dharmarajan, Y. Wang, and H.M. Krumholz National trends in heart failure hospital stay rates, 2001 to 2009 J Am Coll Cardiol 61 2013 1078 1088
88. E. Ben-Chetrit, C. Chen-Shuali, E. Zimran, G. Munter, and G. Nesher A simplified scoring tool for prediction of readmission in elderly patients hospitalized in internal medicine departments Isr Med Assoc J 14 2012 752 756
89. J.G. Cleland, K. Chiswell, J.R. Teerlink, S. Stevens, M. Fiuzat, M.M. Givertz, and et al. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) study Circ Heart Fail 7 2014 76 87
90. A. Mangla, J. Kane, E. Beaty, D. Richardson, L.H. Powell, and J.E. Calvin Jr. Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction Am J Cardiol 112 2013 1907 1912
91. F.H. Rutten, W.S. Heddema, G.J. Daggelders, and A.W. Hoes Primary care patients with heart failure in the last year of their life Fam Pract 29 2012 36 42
92. J.A. Ezekowitz, J. Hu, D. Delgado, A.F. Hernandez, P. Kaul, R. Leader, and et al. Acute heart failure: perspectives from a randomized trial and a simultaneous registry Circ Heart Fail 5 2012 735 741
93. L.P. Badano, L.A. Di, P. Bellotti, M.C. Albanese, G. Sinagra, and P.M. Fioretti Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials Ital Heart J 4 2003 84 91
94. J.N. Cohn, D.G. Archibald, S. Ziesche, J.A. Franciosa, W.E. Harston, F.E. Tristani, and et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration cooperative study N Engl J Med 314 1986 1547 1552
95. J.N. Cohn, G. Johnson, S. Ziesche, F. Cobb, G. Francis, F. Tristani, and et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
96. J.N. Cohn, G. Tognoni Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
97. MERIT-HF Investigators Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
98. C.M. O'Connor, R.C. Starling, A.F. Hernandez, P.W. Armstrong, K. Dickstein, V. Hasselblad, and et al. Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
99. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, and et al. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
100. M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, and et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766
101. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, and et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
102. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
103. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., K. Ferdinand, and et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
104. Beta Blocker Evaluation of Survival Trial Investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
105. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
106. SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
107. Y. Harris, P.B. Gorelick, P. Samuels, and I. Bempong Why African Americans may not be participating in clinical trials J Natl Med Assoc 88 1996 630 634
108. M. Jessup, and I.L. Pina Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J Thorac Cardiovasc Surg 127 2004 1247 1252
109. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
110. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J Am Coll Cardiol 33 1999 1948 1955
111. F. Edelmann, R. Wachter, A.G. Schmidt, E. Kraigher-Krainer, C. Colantonio, W. Kamke, and et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
112. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, and et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
113. B. Pitt, M.A. Pfeffer, S.F. Assmann, R. Boineau, I.S. Anand, B. Claggett, and et al. Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392
114. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, G. Lewis, and et al. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: a randomized clinical trial JAMA 2013 1 10
115. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, and et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
116. M.N. Walsh, C.W. Yancy, N.M. Albert, A.B. Curtis, M. Gheorghiade, J.T. Heywood, and et al. Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF J Card Fail 16 2010 940 949
117. D.E. Feldman, A. Ducharme, N. Giannetti, M. Frenette, C. Michel, F. Grondin, and et al. Outcomes for women and men who attend a heart failure clinic: results of a 12-month longitudinal study J Card Fail 17 2011 540 546
118. S.S. Martin, F.S. Ou, L.K. Newby, V. Sutton, P. Adams, G.M. Felker, and et al. Patient- and trial-specific barriers to participation in cardiovascular randomized clinical trials J Am Coll Cardiol 61 2013 762 769
119. E.L. Ding, N.R. Powe, J.E. Manson, N.S. Sherber, and J.B. Braunstein Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials Arch Intern Med 167 2007 905 912
120. E.D. Peterson, B.L. Lytle, M.S. Biswas, and L. Coombs Willingness to participate in cardiac trials Am J Geriatr Cardiol 13 2004 11 15
121. M. Sen Biswas, L.K. Newby, L.A. Bastian, E.D. Peterson, and J. Sugarman Who refuses enrollment in cardiac clinical trials? Clin Trials 4 2007 258 263
122. M.C. Petrie, N.F. Dawson, D.R. Murdoch, A.P. Davie, and J.J. McMurray Failure of women's hearts Circulation 99 1999 2334 2341
123. M. Komajda, O. Hanon, M. Hochadel, J.L. Lopez-Sendon, F. Follath, P. Ponikowski, and et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur Heart J 30 2009 478 486
124. S. Johansson, M.A. Wallander, A. Ruigomez, and L.A. Garcia Rodriguez Incidence of newly diagnosed heart failure in UK general practice Eur J Heart Fail 3 2001 225 231
125. F.H. Rutten, D.E. Grobbee, and A.W. Hoes Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice Eur J Heart Fail 5 2003 337 344
126. E. Brown, V. Ojeda, R. Wyn, and R. Levan Racial and ethnic disparities in access to health insurance and health care 2000 UCLA Center for Health Policy Research and Henry J. Kaiser Family Foundation Los Angeles
127. D.V. Exner, D.L. Dries, M.J. Domanski, and J.N. Cohn Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction N Engl J Med 344 2001 1351 1357
128. P.G. Shekelle, M.W. Rich, S.C. Morton, C.S. Atkinson, W. Tu, M. Maglione, and et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials J Am Coll Cardiol 41 2003 1529 1538
129. S. Goldstein, P. Deedwania, S. Gottlieb, and J. Wikstrand Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure) Am J Cardiol 92 2003 478 480
130. C.W. Yancy, M.B. Fowler, W.S. Colucci, E.M. Gilbert, M.R. Bristow, J.N. Cohn, and et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure N Engl J Med 344 2001 1358 1365
131. J.N. Cohn, S.W. Tam, I.S. Anand, A.L. Taylor, M.L. Sabolinski, and M. Worcel Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT J Card Fail 13 2007 331 339
132. D.M. McNamara, S.W. Tam, M.L. Sabolinski, P. Tobelmann, K. Janosko, L. Venkitachalam, and et al. Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial J Card Fail 15 2009 191 198
133. J. Lindenfeld, N.M. Albert, J.P. Boehmer, S.P. Collins, J.A. Ezekowitz, M.M. Givertz, and et al. HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 e194
134. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
135. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Bohm, K. Dickstein, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
136. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, and et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
137. S.A. Farmer, J.N. Kirkpatrick, P.A. Heidenreich, J.P. Curtis, Y. Wang, and P.W. Groeneveld Ethnic and racial disparities in cardiac resynchronization therapy Heart Rhythm 6 2009 325 331
138. J.E. Mitchell, A.S. Hellkamp, D.B. Mark, J. Anderson, J.E. Poole, K.L. Lee, and et al. Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Am Heart J 155 2008 501 506
139. A.F. Hernandez, G.C. Fonarow, L. Liang, S.M. Al-Khatib, L.H. Curtis, K.A. LaBresh, and et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 2007 1525 1532
140. A.Y. Sun, J.I. Koontz, S.H. Shah, J.P. Piccini, K.R. Nilsson Jr., D. Craig, and et al. The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction Circ Cardiovasc Genet 4 2011 163 168
141. A. Aggarwal, A. Gupta, P.S. Pappas, A. Tatooles, and G. Bhat Racial differences in patients with left ventricular assist devices ASAIO J 58 2012 499 502
142. A. Tsiouris, R.J. Brewer, J. Borgi, H. Nemeh, G. Paone, and J.A. Morgan Continuous-flow left ventricular assist device implantation as a bridge to transplantation or destination therapy: racial disparities in outcomes J Heart Lung Transplant 32 2013 299 304
143. T.P. Singh, C. Almond, M.M. Givertz, G. Piercey, and K. Gauvreau Improved survival in heart transplant recipients in the United States: racial differences in era effect Circ Heart Fail 4 2011 153 160
144. L.A. Blauwet, S.N. Hayes, D. McManus, R.F. Redberg, and M.N. Walsh Low rate of sex-specific result reporting in cardiovascular trials Mayo Clin Proc 82 2007 166 170
145. E.S. Kim, T.P. Carrigan, and V. Menon Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion J Am Coll Cardiol 52 2008 672 673
146. R. Garg, S. Yusuf Collaborative Group on ACE Inhibitor Trials Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
147. J.K. Ghali, I.L. Pina, S.S. Gottlieb, P.C. Deedwania, and J.C. Wikstrand Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) Circulation 105 2002 1585 1591
148. S.S. Rathore, Y. Wang, and H.M. Krumholz Sex-based differences in the effect of digoxin for the treatment of heart failure N Engl J Med 347 2002 1403 1411
149. K.F. Adams Jr., J.H. Patterson, W.A. Gattis, C.M. O'Connor, C.R. Lee, T.A. Schwartz, and et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis J Am Coll Cardiol 46 2005 497 504
150. E.J. Eichhorn, and M. Gheorghiade Digoxin - new perspective on an old drug N Engl J Med 347 2002 1394 1395
151. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, H. Shi, and et al. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
152. A.L. Taylor, J. Lindenfeld, S. Ziesche, M.N. Walsh, J.E. Mitchell, K. Adams, and et al. Outcomes by gender in the African-American Heart Failure Trial J Am Coll Cardiol 48 2006 2263 2267
153. P.J. Boyles, G.M. Peterson, M.D. Bleasel, and J.H. Vial Undertreatment of congestive heart failure in an Australian setting J Clin Pharm Ther 29 2004 15 22
154. B. Agvall, and U. Dahlstrom Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences Scand J Prim Health Care 19 2001 14 19
155. J. Alaeddini, M.A. Wood, M.S. Amin, and K.A. Ellenbogen Gender disparity in the use of cardiac resynchronization therapy in the United States Pacing Clin Electrophysiol 31 2008 468 472
156. C.W. Yancy, G.C. Fonarow, N.M. Albert, A.B. Curtis, W.G. Stough, M. Gheorghiade, and et al. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Am Heart J 157 2009 754 762
157. L.H. Curtis, S.M. Al-Khatib, A.M. Shea, B.G. Hammill, A.F. Hernandez, and K.A. Schulman Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death JAMA 298 2007 1517 1524
158. A. Arshad, A.J. Moss, E. Foster, L. Padeletti, A. Barsheshet, I. Goldenberg, and et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial J Am Coll Cardiol 57 2011 813 820
159. R. Zusterzeel, K.A. Selzman, and W.E. Sanders Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data JAMA Intern Med 174 2014 1340 1348
160. C.M. Albert, R. Quigg, S. Saba, N.A. Estes III, A. Shaechter, H. Subacius, and et al. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy Am Heart J 156 2008 367 372
161. A.M. Russo, J.E. Poole, D.B. Mark, J. Anderson, A.S. Hellkamp, K.L. Lee, and et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial J Cardiovasc Electrophysiol 19 2008 720 724
162. J.E. Wilcox, G.C. Fonarow, Y. Zhang, N.M. Albert, A.B. Curtis, M. Gheorghiade, and et al. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF Circ Heart Fail 7 2014 146 153
163. R.C. Bogaev, S.V. Pamboukian, S.A. Moore, L. Chen, R. John, A.J. Boyle, and et al. Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation J Heart Lung Transplant 30 2011 515 522
164. E.M. Hsich, D.C. Naftel, S.L. Myers, E.Z. Gorodeski, K.L. Grady, D. Schmuhl, and et al. Should women receive left ventricular assist device support? Findings from INTERMACS Circ Heart Fail 5 2012 234 240
165. L.S. Fragomeni, and M.P. Kaye The Registry of the International Society for Heart Transplantation: fifth official report - 1988 J Heart Transplant 7 1988 249 253
166. US Department of Health and Human Services. The United Network for Organ Sharing. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed June 24, 2014.
167. M.E. Wechsler, E.G. Giardina, R.R. Sciacca, E.A. Rose, and M.L. Barr Increased early mortality in women undergoing cardiac transplantation Circulation 91 1995 1029 1035
168. M.R. Johnson, D.C. Naftel, R.E. Hobbs, J.A. Kobashigawa, D.E. Pitts, T.B. Levine, and et al. The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group J Heart Lung Transplant 16 1997 801 812
169. K.D. Aaronson, J.S. Schwartz, J.E. Goin, and D.M. Mancini Sex differences in patient acceptance of cardiac transplant candidacy Circulation 91 1995 2753 2761
170. C.M. O'Connor, D.J. Whellan, K.L. Lee, S.J. Keteyian, L.S. Cooper, S.J. Ellis, and et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial JAMA 301 2009 1439 1450
171. I.L. Pina, V. Bittner, R.M. Clare, A. Swank, A. Kao, R. Safford, and et al. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training) by sex JACC Heart Fail 2 2014 180 186
172. M.M. Givertz Cardiology patient page: peripartum cardiomyopathy Circulation 127 2013 e622 e626
173. D. Kolte, S. Khera, W.S. Aronow, C. Palaniswamy, M. Mujib, C. Ahn, and et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study J Am Heart Assoc 3 2014 e001056
174. G.D. Pearson, J.C. Veille, S. Rahimtoola, J. Hsia, C.M. Oakley, J.D. Hosenpud, and et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review JAMA 283 2000 1183 1188
175. D.P. Kao, E. Hsich, and J. Lindenfeld Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy JACC Heart Fail 1 2013 409 416
176. T.M. Aziz, M.I. Burgess, N.N. Acladious, C.S. Campbell, A.N. Rahman, N. Yonan, and et al. Heart transplantation for peripartum cardiomyopathy: a report of three cases and a literature review Cardiovasc Surg 7 1999 565 567
177. K. Sliwa, D. Hilfiker-Kleiner, M.C. Petrie, A. Mebazaa, B. Pieske, E. Buchmann, and et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy Eur J Heart Fail 12 2010 767 778
178. D. Hilfiker-Kleiner, and K. Sliwa Pathophysiology and epidemiology of peripartum cardiomyopathy Nat Rev Cardiol 11 2014 364 370
179. M. Barents, I.C. van der Horst, A.A. Voors, J.L. Hillege, F.A. Muskiet, and M.J. de Jongste Prevalence and misdiagnosis of chronic heart failure in nursing home residents: the role of B-type natriuretic peptides Neth Heart J 16 2008 123 128
180. J.C. Kelder, M.J. Cramer, J. van Wijngaarden, R. van Tooren, A. Mosterd, K.G. Moons, and et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure Circulation 124 2011 2865 2873
181. A. Vyshedskiy, R.M. Alhashem, R. Paciej, M. Ebril, I. Rudman, J.J. Fredberg, and et al. Mechanism of inspiratory and expiratory crackles Chest 135 2009 156 164
182. A. Vyshedskiy, S. Ishikawa, and R.L. Murphy Jr. Crackle pitch and rate do not vary significantly during a single automated-auscultation session in patients with pneumonia, congestive heart failure, or interstitial pulmonary fibrosis Respir Care 56 2011 806 817
183. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, and J.C. Burnett Jr. Plasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 40 2002 976 982
184. T.J. Wang, M.G. Larson, D. Levy, E.P. Leip, E.J. Benjamin, P.W. Wilson, and et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults Am J Cardiol 90 2002 254 258
185. J.B. Braunstein, G.F. Anderson, G. Gerstenblith, W. Weller, M. Niefeld, R. Herbert, and et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 2003 1226 1233
186. J.B. Schwartz, and D.P. Zipes Cardiovascular disease in the elderly R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby, Braunwald's heart disease: a textbook of cardiovascular medicine 2011 Elsevier Saunders Philadelphia
187. E.R. Heerdink, H.G. Leufkens, R.M. Herings, J.P. Ottervanger, B.H. Stricker, and A. Bakker NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics Arch Intern Med 158 1998 1108 1112
188. J. Page, and D. Henry Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem Arch Intern Med 160 2000 777 784
189. P. Gastelurrutia, S.I. Benrimoj, J. Espejo, L. Tuneu, M.A. Mangues, and A. Bayes-Genis Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic J Card Fail 17 2011 217 223
190. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
191. C.Y. Jurgens, S.J. Goodlin, M. Dolansky, A. Ahmed, G.C. Fonarow, R. Boxer, and et al. Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America J Card Fail 21 2015 263 299
192. J. Afilalo, S. Karunananthan, M.J. Eisenberg, K.P. Alexander, and H. Bergman Role of frailty in patients with cardiovascular disease Am J Cardiol 103 2009 1616 1621
193. K. Murad, and D.W. Kitzman Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management Heart Fail Rev 17 2012 581 588
194. M.D. Flather, M.C. Shibata, A.J. Coats, D.J. van Veldhuisen, A. Parkhomenko, J. Borbola, and et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225
195. A. Spinewine, K.E. Schmader, N. Barber, C. Hughes, K.L. Lapane, C. Swine, and et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370 2007 173 184
196. L.H. Beck Changes in renal function with aging Clin Geriatr Med 14 1998 199 209
197. A.E. Luckey, and C.J. Parsa Fluid and electrolytes in the aged Arch Surg 138 2003 1055 1060
198. M.W. Rich, F. McSherry, W.O. Williford, and S. Yusuf Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study J Am Coll Cardiol 38 2001 806 813
199. P. Santangeli, L. Di Biase, A. Dello Russo, M. Casella, S. Bartoletti, P. Santarelli, and et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators Ann Intern Med 153 2010 592 599
200. C.M. Tracy, A.E. Epstein, D. Darbar, J.P. DiMarco, S.B. Dunbar, N.A. Estes III, and et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [corrected] Circulation 126 2012 1784 1800
201. F.H. Verbrugge, M. Dupont, P. De Vusser, M. Rivero-Ayerza, H. Van Herendael, J. Vercammen, and et al. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians Eur J Heart Fail 15 2013 203 210
202. P. Atluri, A.B. Goldstone, D.M. Kobrin, J.E. Cohen, J.W. MacArthur, J.L. Howard, and et al. Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study Ann Thorac Surg 96 2013 141 147
203. R.M. Adamson, M. Stahovich, S. Chillcott, S. Baradarian, J. Chammas, B. Jaski, and et al. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the Heartmate II left ventricular assist device: a community hospital experience J Am Coll Cardiol 57 2011 2487 2495
204. D.J. Goldstein, R. Bello, J.J. Shin, G. Stevens, R. Zolty, S. Maybaum, and et al. Outcomes of cardiac transplantation in septuagenarians J Heart Lung Transplant 31 2012 679 685
205. E.S. Weiss, L.U. Nwakanma, N.D. Patel, and D.D. Yuh Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database J Heart Lung Transplant 27 2008 184 191
206. N. Ferrara, K. Komici, G. Corbi, G. Pagano, G. Furgi, C. Rengo, and et al. β-adrenergic receptor responsiveness in aging heart and clinical implications Front Physiol 4 2014 396
207. Y.M. Chen, and Y. Li Safety and efficacy of exercise training in elderly heart failure patients: a systematic review and meta-analysis Int J Clin Pract 67 2013 1192 1198
208. D.W. Kitzman, P.H. Brubaker, T.M. Morgan, K.P. Stewart, and W.C. Little Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial Circ Heart Fail 3 2010 659 667
209. P. Erceg, N. Despotovic, D.P. Milosevic, I. Soldatovic, S. Zdravkovic, S. Tomic, and et al. Health-related quality of life in elderly patients hospitalized with chronic heart failure Clin Interv Aging 8 2013 1539 1546
210. M. Gott, S. Barnes, C. Parker, S. Payne, D. Seamark, S. Gariballa, and et al. Predictors of the quality of life of older people with heart failure recruited from primary care Age Ageing 35 2006 172 177
211. P.A. Heidenreich, J.A. Spertus, P.G. Jones, W.S. Weintraub, J.S. Rumsfeld, S.S. Rathore, and et al. Health status identifies heart failure outpatients at risk for hospitalization or death J Am Coll Cardiol 47 2006 752 756
212. T. Hoekstra, T. Jaarsma, D.J. van Veldhuisen, H.L. Hillege, R. Sanderman, and I. Lesman-Leegte Quality of life and survival in patients with heart failure Eur J Heart Fail 15 2013 94 102
213. S.M. Joseph, E. Novak, S.V. Arnold, P.G. Jones, H. Khattak, A.E. Platts, and et al. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction Circ Heart Fail 6 2013 1139 1146
214. N. Kato, K. Kinugawa, S. Seki, T. Shiga, M. Hatano, A. Yao, and et al. Quality of life as an independent predictor for cardiac events and death in patients with heart failure Circ J 75 2011 1661 1669
215. M.C. Zuluaga, P. Guallar-Castillon, E. Lopez-Garcia, J.R. Banegas, M. Conde-Herrera, M. Olcoz-Chiva, and et al. Generic and disease-specific quality of life as a predictor of long-term mortality in heart failure Eur J Heart Fail 12 2010 1372 1378
216. Y. Li, M.P. Neilson, D.J. Whellan, K.A. Schulman, W.C. Levy, and S.D. Reed Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION J Card Fail 19 2013 311 316
217. M. Gott, S. Barnes, C. Parker, S. Payne, D. Seamark, S. Gariballa, and et al. Dying trajectories in heart failure Palliat Med 21 2007 95 99
218. H.P. Brunner-La Rocca, P. Rickenbacher, S. Muzzarelli, R. Schindler, M.T. Maeder, U. Jeker, and et al. End-of-life preferences of elderly patients with chronic heart failure Eur Heart J 33 2012 752 759
219. I.H. Kraai, K.M. Vermeulen, M.L. Luttik, T. Hoekstra, T. Jaarsma, and H.L. Hillege Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail 15 2013 1113 1121
220. L.W. Stevenson, A.S. Hellkamp, C.V. Leier, G. Sopko, T. Koelling, J.W. Warnica, and et al. Changing preferences for survival after hospitalization with advanced heart failure J Am Coll Cardiol 52 2008 1702 1708